TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 27, 2023
Super excited for tomorrow's ER Guidance Call ... See more
Jan, 21, 2023
They're FDA approved, have the best in class t... See more
AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Feb, 14, 2023
$AVXL I am extremely bullish on the data .. the F... See more
Feb, 5, 2023
Guys from the fda that really know their stuff.
SAVA
Cassava Sciences Inc
-13.96%
$29.88 - $25.71
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $M... See more
Jan, 6, 2023
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
Feb, 27, 2023
Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!
Jan, 21, 2023
They're FDA approved, have the best in class treatment, and is more affordable than the others.
Dec, 30, 2022
$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE
Dec, 30, 2022
$KALA up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 & $TGTX is up 13% continued momentum following MS drug approvals.
Dec, 30, 2022
Our best in class drug is FDA APPROVED.
Dec, 30, 2022
$TGTX $KALA $HOTH $NUWE TGTX on fire š„ and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.
Dec, 30, 2022
Great FDA approval news in a growing MS market with a need.
Dec, 30, 2022
$TGTX , absolutely amazingā¦.Scumbagās Bank of America analyst rated TG today as underperform $6ā¦.total jokeā¦.I guess the analyst is waiting for FDA approvalā¦LOL ā¦.stick to loans and mortgagesā¦.very bullish TG community Longsā¦.
Dec, 29, 2022
$TGTX FDA approval for Billion dollar MS drug ā great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up itās sleeve.
Dec, 29, 2022
.. FDA APPROVED ON 12/28/22 BEST IN CLASS .
Feb, 14, 2023
$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions
Feb, 5, 2023
Guys from the fda that really know their stuff.
Jan, 24, 2023
He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.
Jan, 13, 2023
The FDA and global agencies find great comfort in NDAs accompanied by a peer review.
Jan, 6, 2023
look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
With all the scrutiny with on the FDA they will definitely be forced to approve Anavex which is the safest, cheapest on Healthcare and the patients, and most convenient drug.
Jan, 2, 2023
$AVXL good thing they have 50 years of fda expertise on their staff, HandFš
Dec, 29, 2022
This puts alot of scrutiny on the FDA which is good for Anavex.
Dec, 24, 2022
Suddenly the results could look golden and backed by the FDA allowable genetic coding regulations!!
Mar, 21, 2023
$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.
Jan, 6, 2023
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
Jan, 6, 2023
no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !
Dec, 27, 2022
My prediction: Phase 2 Unbelievable results FDA fast track Phase 3 - go ahead Patients receive sava Market cap 40 B by 2024 Rising to 200 Billion by 2026 Game changer - the only drug in the world to help patients
Nov, 6, 2022
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
Oct, 26, 2022
FDA, do the right thing this time!
Oct, 6, 2022
$SAVA the drug is 100% safe the fda has nothing to lose if they approve it for compassionate use.
Oct, 6, 2022
Should be place on fast track by the FDA!